1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing technological advancements in the field of sequencing technologies in transcriptomics research. Similarly, the increasing government and private funding for research coupled with research and development investments by the biotechnology companies are expected to drive the transcriptomics market. The increasing adoption of transcriptomics in the field of biomarker discovery opens new growth avenues with the rising preference of personalized medicine across the globe. However, the higher investment costs that restrict the adoption of transcriptomics products and dearth of skilled professionals are the factors hampering the growth of this market to a certain extent.

The transcriptomics market report covers the transcriptomic technologies, applications and end-users. The technologies market in this report is segmented as microarray, PCR, sequencing technologies which include Sanger sequencing and NGS, and RNAi gene silencing technology. Each of these technologies market is further sub-segmented into reagents, instruments and software. The applications of transcriptomics covered under the scope of this report are clinical diagnostics, drug discovery, and toxicogenomics. The end-users of transcriptomics are pharmaceutical and biotechnology companies, academic research and government institutes, and hospitals and diagnostic centers. This report also discusses the key market drivers, restraints, opportunities, challenges, and trends in the global transcriptomics market and its submarkets.

By 2019, North America will continue to dominate and drive the transcriptomics market, primarily due to the rising preference for personalized medicines which use biomarkers developed with the transcriptomic technologies. On the other hand, the market in Asia-Pacific region is expected to grow at a highest CAGR during the forecast period mainly due to the growing pharmaceutical and biotech industries in China and India. The reduction in funding for research and development coupled with decrease in the investment in research by the pharmaceutical and biotechnology companies in the European region as a means of cost containment is expected to hamper the growth of transcriptomics market in Europe.

The prominent players in the global trancriptomics market are Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), and Thermofisher Scientific Inc. (U.S.).

Reasons to Buy the Report

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms to garner a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the transcriptomics market. The report analyzes the transcriptomics market by technology, application, end-user and geography covering North America, Europe, APAC, and RoW
- Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the transcriptomics market
- Market Development: Comprehensive information on the lucrative emerging markets for transcriptomics market by technology, application, and end-user by product types
- Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the transcriptomics
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, manufacturing capabilities, and SWOT analyses of the leading players in the transcriptomics market

Table Of Contents

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
1 INTRODUCTION 18

1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET SCOPE 18
1.3 MARKETS COVERED 19
1.4 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21

2.1 RESEARCH APPROACH 21
2.2 MARKET SIZE ESTIMATION 23
2.3 MARKET CRACKDOWN AND DATA TRIANGULATION 25
2.4 MARKET SHARE ESTIMATION 26
2.5 KEY DATA FROM SECONDARY SOURCES 26
2.6 KEY DATA FROM PRIMARY SOURCES 26
2.6.1 KEY INDUSTRY INSIGHTS 27
2.7 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 30

4.1 GROWTH POTENTIAL OF THE TRANSCRIPTOMICS MARKET 30
4.2 TRANSCRIPTOMICS TECHNOLOGIES MARKET IN ASIA-PACIFIC 31
4.3 TRANSCRIPTOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32
4.4 TRANSCRIPTOMICS TECHNOLOGIES MARKET: DEVELOPED VS. DEVELOPING NATIONS 33
4.5 LIFE CYCLE ANALYSIS BY GEOGRAPHY 34
4.6 MARKET CHASM ANALYSIS 35

5 MARKET OVERVIEW 36

5.1 INTRODUCTION 36
5.2 EVOLUTION 36
5.3 MARKET SEGMENTATION 37
5.3.1 TRANSCRIPTOMICS TECHNOLOGIES MARKET, BY TYPE 37
5.3.2 TRANSCRIPTOMICS TECHNOLOGIES MARKET, BY APPLICATION 38
5.3.3 GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, BY END USER 38
5.4 MARKET DYNAMICS 39
5.5 KEY MARKET DRIVERS 40
5.5.1 GROWING APPLICATIONS OF RNA SEQUENCING IN TRANSCRIPTOMICS RESEARCH TO DRIVE MARKET GROWTH 40
5.5.2 INCREASED RESEARCH AND DEVELOPMENT SPENDING BY BIOTECHNOLOGY COMPANIES TO BOOST TRANSCRIPTOMICS MARKET 40
5.5.3 INCREASING PREFERENCE FOR PERSONALIZED MEDICINE TO FURTHER PROPEL TRANSCRIPTOMICS TECHNOLOGIES MARKET 40
5.5.4 AVAILABILITY OF GOVERNMENT AND PRIVATE FUNDING TO DRIVE TRANSCRIPTOMICS TECHNOLOGIES MARKET 41
5.6 KEY MARKET RESTRAINTS 42
5.6.1 NEED OF HIGH CAPITAL INVESTMENT LIMITS ADOPTION OF TRANSCRIPTOMIC TECHNOLOGIES 42
5.6.2 DEARTH OF SKILLED PROFESSIONALS HINDERING GREATER ADOPTION OF TRANSCRIPTOMIC TECHNOLOGIES 43
5.7 KEY MARKET OPPORTUNITIES 44
5.7.1 SIGNIFICANT OPPORTUNITIES FOR TRANSCRIPTOMIC TECHNOLOGIES IN THE FIELD OF BIOMARKER DISCOVERY 44
5.7.2 EMERGING AND UNTAPPED MARKETS PRESENT OPPORTUNITIES 44
5.7.3 TOXICOGENOMICS AS AN APPLICATION TO OPEN NEW GROWTH AVENUES 44
5.8 KEY CHALLENGES 46
5.8.1 LACK OF EFFECTIVE BIOINFORMATICS TOOLS FOR TRANSCRIPTOMIC ANALYSIS 46

6 INDUSTRY TRENDS 47

6.1 INTRODUCTION 47
6.2 PORTER'S FIVE FORCES ANALYSIS 48
6.2.1 THREAT FROM NEW ENTRANTS 48
6.2.2 THREAT FROM SUBSTITUTES 49
6.2.3 BARGAINING POWER OF BUYERS 49
6.2.4 BARGAINING POWER OF SUPPLIERS 50
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 50
6.3 STRATEGIC BENCHMARKING 50
6.3.1 NEW PRODUCT LAUNCHES 51

7 TRANSCRIPTOMICS TECHNOLOGIES MARKET, BY TYPE 52

7.1 INTRODUCTION 53
7.2 POLYMERASE CHAIN REACTION (PCR) 55
7.2.1 PCR REAGENTS 56
7.2.2 PCR INSTRUMENTS 57
7.2.3 PCR SOFTWARE 58
7.3 SEQUENCING TECHNOLOGIES 59
7.3.1 REAGENTS 61
7.3.2 INSTRUMENTS 62
7.3.3 SOFTWARE 63
7.3.4 SANGER SEQUENCING 64
7.3.5 NEXT-GENERATION SEQUENCING (NGS) 65
7.4 MICROARRAYS 65
7.4.1 MICROARRAY REAGENTS 67
7.4.2 MICROARRAY INSTRUMENTS 68
7.4.3 MICROARRAY SOFTWARE 68
7.5 RNAI GENE SILENCING 70
7.5.1 RNAI GENE SILENCING REAGENTS 71
7.5.2 RNAI GENE SILENCING INSTRUMENTS 72
7.5.3 RNAI GENE SILENCING SOFTWARE 73

8 GLOBAL TRANSCRIPTOMICS MARKET, BY APPLICATION 75

8.1 INTRODUCTION 76
8.1.1 DRUG DISCOVERY 76
8.1.2 CLINICAL DIAGNOSTICS 77
8.1.3 TOXICOGENOMICS 78

9 GLOBAL TRANSCRIPTOMICS MARKET, BY END USER 80

9.1 INTRODUCTION 81
9.2 ACADEMIC RESEARCH and GOVERNMENT INSTITUTES 81
9.3 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES 82
9.4 HOSPITALS and DIAGNOSTIC CENTERS 83

10 GLOBAL TRANSCRIPTOMICS MARKET, BY GEOGRAPHY 85

10.1 INTRODUCTION 86
10.2 NORTH AMERICA 88
10.2.1 U.S. 92
10.2.2 CANADA 95
10.2.3 MEXICO 98
10.3 EUROPE 101
10.3.1 GERMANY 104
10.3.2 U.K. 107
10.3.3 FRANCE 110
10.3.4 ITALY 112
10.3.5 SPAIN 115
10.3.6 REST OF EUROPE (ROE) 118
10.4 ASIA-PACIFIC 120
10.4.1 CHINA 124
10.4.2 JAPAN 127
10.4.3 INDIA 130
10.4.4 REST OF ASIA-PACIFIC 132
10.5 REST OF THE WORLD 135
10.5.1 LATIN AMERICA 138
10.5.2 MIDDLE EAST and AFRICA 141

11 COMPETITIVE LANDSCAPE 144

11.1 OVERVIEW 144
11.2 MARKET SHARE ANALYSIS 145
11.3 COMPETITIVE SITUATION AND TRENDS 147
11.3.1 NEW PRODUCT LAUNCHES 147
11.3.2 AGREEMENTS, PARTNERSHIPS, and COLLABORATIONS 148
11.3.3 MERGERS and ACQUISITIONS 149
11.3.4 EXPANSIONS 150
11.3.5 PRODUCT ENHANCEMENTS 151

12 COMPANY PROFILES 153

12.1 AFFYMETRIX INC. 154
12.2 AGILENT TECHNOLOGIES, INC. 158
12.3 BIO-RAD LABORATORIES, INC. 161
12.4 GE HEALTHCARE 163
12.5 ILLUMINA, INC. 165
12.6 QIAGEN N.V. 170
12.7 F. HOFFMANN-LA ROCHE LTD. 174
12.8 SIGMA-ALDRICH CORPORATION 176
12.9 THERMO FISHER SCIENTIFIC, INC. 179
12.10 FLUIDIGM CORPORATION 182
*Details on Business Overview, Products and Services, Key Strategy, and Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX 184

13.1 INSIGHTS OF INDUSTRY EXPERTS 184
13.2 DISCUSSION GUIDE 185
13.3 AVAILABLE CUSTOMIZATIONS 189
13.4 RELATED REPORTS 190
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 190

LIST OF TABLES

TABLE 1 GROWING RandD SPENDING AND INCREASING PREFERENCE FOR PERSONALIZED MEDICINES TO FUEL GROWTH OF TRANSCRIPTOMICS MARKET 41
TABLE 2 NEED OF HIGH CAPITAL INVESTMENT AND DEARTH OF SKILLED PROFESSIONALS MAY LIMIT UPTAKE OF TRANSCRIPTOMIC TECHNOLOGIES 43
TABLE 3 NOVEL BIOMARKER DISCOVERY AND TOXICOGENOMICS TO OPEN NEW GROWTH OPPORTUNITIES 45
TABLE 4 LACK OF EFFECTIVE BIOINFORMATICS TOOLS POSES THE BIGGEST CHALLENGE FOR TRANSCRIPTOMICS 46
TABLE 5 GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 54
TABLE 6 GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 54
TABLE 7 GLOBAL TRANSCRIPTOMICS PCR MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 56
TABLE 8 GLOBAL TRANSCRIPTOMICS PCR MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 56
TABLE 9 GLOBAL TRANSCRIPTOMICS PCR REAGENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 57
TABLE 10 GLOBAL TRANSCRIPTOMICS PCR INSTRUMENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 58
TABLE 11 GLOBAL TRANSCRIPTOMICS PCR SOFTWARE MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 59
TABLE 12 GLOBAL TRANSCRIPTOMICS SEQUENCING MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 60
TABLE 13 GLOBAL TRANSCRIPTOMICS SEQUENCING MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 60
TABLE 14 GLOBAL TRANSCRIPTOMICS SEQUENCING REAGENTS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 62
TABLE 15 GLOBAL TRANSCRIPTOMICS SEQUENCING INSTRUMENTS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 63
TABLE 16 GLOBAL TRANSCRIPTOMICS SEQUENCING SOFTWARE MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 64
TABLE 17 GLOBAL TRANSCRIPTOMICS MICROARRAYS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 66
TABLE 18 GLOBAL TRANSCRIPTOMICS MICROARRAYS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 66
TABLE 19 GLOBAL TRANSCRIPTOMICS MICROARRAY REAGENTS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 67
TABLE 20 GLOBAL TRANSCRIPTOMICS MICROARRAY INSTRUMENTS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 68
TABLE 21 GLOBAL TRANSCRIPTOMICS MICROARRAY SOFTWARE MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 69
TABLE 22 GLOBAL TRANSCRIPTOMICS RNAI GENE SILENCING MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 70
TABLE 23 GLOBAL TRANSCRIPTOMICS RNAI GENE SILENCING MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 71
TABLE 24 GLOBAL TRANSCRIPTOMICS RNAI GENE SILENCING REAGENTS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 72
TABLE 25 GLOBAL TRANSCRIPTOMICS RNAI GENE SILENCING INSTRUMENTS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 73
TABLE 26 GLOBAL TRANSCRIPTOMICS RNAI GENE SILENCING SOFTWARE MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 74
TABLE 27 GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 76
TABLE 28 GLOBAL TRANSCRIPTOMICS MARKET SIZE FOR DRUG DISCOVERY,
BY GEOGRAPHY, 2012-2019 ($MILLION) 77
TABLE 29 GLOBAL TRANSCRIPTOMICS MARKET SIZE FOR CLINICAL DIAGNOSTICS,
BY GEOGRAPHY, 2012-2019 ($MILLION) 78
TABLE 30 GLOBAL TRANSCRIPTOMICS MARKET SIZE FOR TOXICOGENOMICS,
BY GEOGRAPHY, 2012-2019 ($MILLION) 79
TABLE 31 GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 81
TABLE 32 GLOBAL TRANSCRIPTOMICS MARKET SIZE FOR ACADEMIC RESEARCH and GOVERNMENT INSTITUTES, BY GEOGRAPHY, 2012-2019 ($MILLION) 82
TABLE 33 GLOBAL TRANSCRIPTOMICS MARKET SIZE FOR PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2012-2019 ($MILLION) 83
TABLE 34 GLOBAL TRANSCRIPTOMICS MARKET SIZE FOR HOSPITALS and DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2012-2019 ($MILLION) 84
TABLE 35 GLOBAL TRANSCRIPTOMICS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 86
TABLE 36 NORTH AMERICA: TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 90
TABLE 37 NORTH AMERICA: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 90
TABLE 38 NORTH AMERICA: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 90
TABLE 39 NORTH AMERICA: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 91
TABLE 40 NORTH AMERICA: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 91
TABLE 41 NORTH AMERICA: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 91
TABLE 42 NORTH AMERICA: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 92
TABLE 43 NORTH AMERICA: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 92
TABLE 44 U.S. : TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 93
TABLE 45 U.S. : TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 93
TABLE 46 U.S.: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 94
TABLE 47 U.S.: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 94
TABLE 48 U.S.: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 94
TABLE 49 U.S.: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 95
TABLE 50 U.S.: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 95
TABLE 51 CANADA : TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 96
TABLE 52 CANADA: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 96
TABLE 53 CANADA : TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 96
TABLE 54 CANADA: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 97
TABLE 55 CANADA: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 97
TABLE 56 CANADA: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 97
TABLE 57 CANADA: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 98
TABLE 58 MEXICO: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 99
TABLE 59 MEXICO: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 99
TABLE 60 MEXICO: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 99
TABLE 61 MEXICO: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 100
TABLE 62 MEXICO: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 100
TABLE 63 MEXICO: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 100
TABLE 64 MEXICO: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 101
TABLE 65 EUROPE: TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 102
TABLE 66 EUROPE: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 102
TABLE 67 EUROPE: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 102
TABLE 68 EUROPE: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 103
TABLE 69 EUROPE: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 103
TABLE 70 EUROPE: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 103
TABLE 71 EUROPE: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 104
TABLE 72 EUROPE: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 104
TABLE 73 GERMANY: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 105
TABLE 74 GERMANY: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 105
TABLE 75 GERMANY: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 105
TABLE 76 GERMANY : TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 106
TABLE 77 GERMANY: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 106
TABLE 78 GERMANY: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 106
TABLE 79 GERMANY: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 107
TABLE 80 U.K.: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 107
TABLE 81 U.K.: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 108
TABLE 82 U.K.: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 108
TABLE 83 U.K.: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 108
TABLE 84 U.K.: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 109
TABLE 85 U.K.: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 109
TABLE 86 U.K.: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 109
TABLE 87 FRANCE: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 110
TABLE 88 FRANCE: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 110
TABLE 89 FRANCE: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 111
TABLE 90 FRANCE: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 111
TABLE 91 FRANCE: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 111
TABLE 92 FRANCE: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 112
TABLE 93 FRANCE: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 112
TABLE 94 ITALY: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 113
TABLE 95 ITALY: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 113
TABLE 96 ITALY: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 113
TABLE 97 ITALY: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 114
TABLE 98 ITALY: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 114
TABLE 99 ITALY: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 114
TABLE 100 ITALY: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 115
TABLE 101 SPAIN: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 115
TABLE 102 SPAIN : TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 116
TABLE 103 SPAIN: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 116
TABLE 104 SPAIN: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 116
TABLE 105 SPAIN: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 117
TABLE 106 SPAIN: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 117
TABLE 107 SPAIN: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 117
TABLE 108 ROE: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 118
TABLE 109 ROE: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 118
TABLE 110 ROE: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 119
TABLE 111 ROE: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 119
TABLE 112 ROE: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 119
TABLE 113 ROE: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 120
TABLE 114 ROE: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 120
TABLE 115 ASIA-PACIFIC: TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY,
2012-2019 ($MILLION) 122
TABLE 116 ASIA-PACIFIC: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 122
TABLE 117 ASIA-PACIFIC: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 122
TABLE 118 ASIA-PACIFIC: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 123
TABLE 119 ASIA-PACIFIC: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 123
TABLE 120 ASIA-PACIFIC: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 123
TABLE 121 ASIA-PACIFIC: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 124
TABLE 122 ASIA-PACIFIC: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 124
TABLE 123 CHINA: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 125
TABLE 124 CHINA: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 125
TABLE 125 CHINA: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 125
TABLE 126 CHINA: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 126
TABLE 127 CHINA: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 126
TABLE 128 CHINA: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 126
TABLE 129 CHINA: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 127
TABLE 130 JAPAN: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 127
TABLE 131 JAPAN: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 128
TABLE 132 JAPAN: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 128
TABLE 133 JAPAN: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 128
TABLE 134 JAPAN: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 129
TABLE 135 JAPAN: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 129
TABLE 136 JAPAN: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 129
TABLE 137 INDIA: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 130
TABLE 138 INDIA: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 130
TABLE 139 INDIA: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 131
TABLE 140 INDIA: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 131
TABLE 141 INDIA: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 131
TABLE 142 INDIA: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 132
TABLE 143 INDIA: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 132
TABLE 144 ROAPAC: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 133
TABLE 145 ROAPAC: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 133
TABLE 146 ROAPAC: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 133
TABLE 147 ROAPAC: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 134
TABLE 148 ROAPAC: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 134
TABLE 149 ROAPAC: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 134
TABLE 150 ROAPAC: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 135
TABLE 151 ROW: TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 135
TABLE 152 ROW: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 136
TABLE 153 ROW: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 136
TABLE 154 ROW: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 136
TABLE 155 ROW: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 137
TABLE 156 ROW: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 137
TABLE 157 ROW: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 137
TABLE 158 ROW: TRANSCRIPTOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 138
TABLE 159 LATIN AMERICA: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 138
TABLE 160 LATIN AMERICA: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 139
TABLE 161 LATIN AMERICA: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 139
TABLE 162 LATIN AMERICA: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2012-2019 ($MILLION) 139
TABLE 163 LATIN AMERICA: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 140
TABLE 164 LATIN AMERICA: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 140
TABLE 165 LATIN AMERICA: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 140
TABLE 166 MIDDLE EAST and AFRICA: TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 141
TABLE 167 MIDDLE EAST and AFRICA: TRANSCRIPTOMICS PCR TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 142
TABLE 168 MIDDLE EAST and AFRICA: TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 142
TABLE 169 MIDDLE EAST and AFRICA: TRANSCRIPTOMICS MICROARRAY TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 142
TABLE 170 MIDDLE EAST and AFRICA: TRANSCRIPTOMICS RNAI GENE SILENCING TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 143
TABLE 171 MIDDLE EAST and AFRICA: TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 143
TABLE 172 MIDDLE EAST and AFRICA: TRANSCRIPTOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 143
TABLE 173 GROWTH STRATEGY MATRIX, 2011-2014 145
TABLE 174 NEW PRODUCT LAUNCHES, 2011-2014 148
TABLE 175 AGREEMENTS, PARTNERSHIPS, and COLLABORATIONS, 2011-2014 148
TABLE 176 MERGERS and ACQUISITIONS, 2011-2014 149
TABLE 177 EXPANSIONS, 2011-2014 150
TABLE 178 PRODUCT ENHANCEMENTS, 2011-2014 151

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 22
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 3 BOTTOM-UP APPROACH 24
FIGURE 4 TOP-DOWN APPROACH 24
FIGURE 5 DATA TRIANGULATION METHODOLOGY 25
FIGURE 6 GLOBAL TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2014 VS 2019 ($MILLION) 28
FIGURE 7 APAC TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD 29
FIGURE 8 MARKET GROWTH TO BE DRIVEN BY INCREASE IN NUMBER OF PHARMACEUTICAL, BIOTECH INDUSTRIES 30
FIGURE 9 PCR TECHNOLOGY CONTRIBUTES A MAJOR SHARE OF THE APAC TRANSCRIPTOMICS MARKET 31
FIGURE 10 U.S. COMMANDS THE MAJOR SHARE IN GLOBAL TRANSCRIPTOMICS MARKET 32
FIGURE 11 DEVELOPING MARKETS TO PROVIDE NEW REVENUE GROWTH POCKETS FOR MARKET PLAYERS 33
FIGURE 12 LATIN AMERICAN MARKET TO ENTER EXPONENTIAL GROWTH PHASE IN COMING YEARS 34
FIGURE 13 RELUCTANCE AMONG TRADITIONAL CLINICIANS TO ADOPT NGS A MAJOR OBSTACLE FOR GROWTH OF THE MARKET 35
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS TO PLAY VITAL ROLE IN THE OMICS INDUSTRY 37
FIGURE 15 GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SEGMENTATION: BY TYPE 37
FIGURE 16 GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET: BY APPLICATION 38
FIGURE 17 GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, BY END USER 38
FIGURE 18 KEY MARKET DYNAMICS 39
FIGURE 19 PORTERS FIVE FORCES ANALYSIS-FRAMEWORK 48
FIGURE 20 ILLUMINA INC. AND AFFYMETRIX INC. LARGELY ADOPTED ORGANIC GROWTH STRATEGIES FROM 2011-2014 51
FIGURE 21 PCR WILL CONTINUE TO DOMINATE THE GLOBAL TRANSCRIPTOMICS MARKET 53
FIGURE 22 ASIA-PACIFIC IS THE MOST LUCRATIVE MARKET FOR TRANSCRIPTOMICS PCR 55
FIGURE 23 ASIA-PACIFIC IS THE MOST LUCRATIVE MARKET FOR TRANSCRIPTOMICS SEQUENCING TECHNOLOGIES 61
FIGURE 24 GEOGRAPHIC SNAPSHOT (2013) - RAPID GROWTH MARKETS ARE EMERGING AS NEW HOT SPOTS 87
FIGURE 25 CHINA TO BE THE MOST LUCRATIVE MARKET FOR ALL THE PRODUCT SEGMENTS, CLOSELY FOLLOWED BY INDIA AND JAPAN 88
FIGURE 26 NORTH AMERICA TRANSCRIPTOMICS MARKET SNAPSHOT: GROWTH WILL BE DRIVEN BY RISING TRANSCRIPTOMICS RandD INVESTMENTS BY BIOTECHNOLOGY and PHARMACEUTICAL COMPANIES 89
FIGURE 27 APAC TRANSCRIPTOMICS MARKET SNAPSHOT - CHINA IS THE MOST LUCRATIVE MARKET 121
FIGURE 28 COMPANIES ADOPTED NEW PRODUCT LAUNCHES AS A KEY GROWTH STRATEGY 144
FIGURE 29 GLOBAL TRANSCRIPTOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 146
FIGURE 30 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES IS THE KEY STRATEGY 147
FIGURE 31 GEOGRAPHIC REVENUE MIX OF LEADING PLAYERS IN THE MARKET 153
FIGURE 32 AFFYMETRIX INC. : COMPANY SNAPSHOT 154
FIGURE 33 AGILENT TECHNOLOGIES INC. : COMPANY SNAPSHOT 158
FIGURE 34 BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT 161
FIGURE 35 GENERAL ELECTRIC CO. : COMPANY SNAPSHOT 163
FIGURE 36 ILLUMINA INC. : COMPANY SNAPSHOT 165
FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT 170
FIGURE 38 F. HOFFMANN-LA ROCHE LTD : COMPANY SNAPSHOT 174
FIGURE 39 SIGMA ALDRICH: COMPANY SNAPSHOT 176
FIGURE 40 THERMOFISHER SCIENTIFIC INC. : COMPANY SNAPSHOT 179
FIGURE 41 FLUIDIGM CORPORATION: COMPANY SNAPSHOT 182

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Agrigenomics Market by Application, Sequencer Type, Objective, and Region - Global Forecast to 2021

Agrigenomics Market by Application, Sequencer Type, Objective, and Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

“The agrigenomics market is projected to grow at a CAGR of 7.8%, in terms of value” The agrigenomics market is projected to reach USD 13.56 billion by 2021. Rising funds toward agrigenomics research ...

US Next-generation Sequencing Services Market

US Next-generation Sequencing Services Market

  • $ 4950
  • Industry report
  • September 2016
  • by Frost & Sullivan

$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation o ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.